Dr. Konstantinos Chronis's lab focuses on how certain factors can transform cells found in blood vessels into hematopoietic stem cells (HSCs), which are vital for producing blood cells. By understanding this reprogramming process, the lab aims to develop new methods for generating HSCs that could be used in medical treatments. Their research explores the genetic changes that happen during this transformation and how to make the process more efficient and effective for clinical applications.

Maxim Frolov's research lab focuses on understanding how certain pathways in cells control their growth and specialization during animal development. Using the fruit fly Drosophila as a simpler model, the lab studies the Retinoblastoma (RB) and Hippo pathways and their roles in cell cycles and how they can lead to diseases when they malfunction. The goal is to gain insights that can potentially inform treatments for conditions like cancer and other growth-related diseases.

Dr. Nissim Hay's lab at the University of Illinois at Chicago focuses on understanding the role of Hexokinase 2 (HK2) in liver fibrosis and liver cancer. The lab investigates how HK2 contributes to the metabolic changes in liver cells during disease and looks for ways to leverage this knowledge for new treatments. Additionally, they explore HK2's role in cancer cell metabolism and its potential as a therapeutic target in various cancers.

Dr. Jalees Rehman's lab at the University of Illinois at Chicago focuses on understanding the interactions between pathogens and the immune system, particularly in the context of diseases like Alzheimer's and lung injuries. The lab investigates how infections can lead to cellular aging and inflammation, impacts on the blood-brain barrier in Alzheimer's patients, and utilizes advanced human organoid models to study lung disease and repair mechanisms. Their work aims to find new therapeutic targets for preventing and treating these conditions.